Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Allen

Showing results (221-230 of 249) with videos related to

Pageof 25
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Frontiers in Psychiatry|May 29, 2019
Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for PsychosisIlaria Bonoldi, Paul Allen, Luis Madeira, et al.
The Journal of Clinical Investigation|January 4, 2021
Atorvastatin is associated with reduced cisplatin-induced hearing lossKatharine A Fernandez, Paul Allen, Maura Campbell, et al.
Psychological Science|June 4, 2021
Correlates of Hallucinatory Experiences in the General Population: An International Multisite Replication StudyPeter Moseley, André Aleman, Paul Allen, et al.
Schizophrenia Bulletin|January 3, 2018
Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second CohortPaul Allen, Matilda Azis, Gemma Modinos, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
Human Brain Mapping|February 21, 2025
The Psychosis MRI Shared Data Resource (Psy-ShareD)Paul Allen, Mariana Zurita, Rubaida Easmin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 18, 2021
Food-induced anaphylaxis morbidity: Emergency department and hospitalization data support preventive strategiesLuciana Kase Tanno, Evangeline Clark, Myriam Mamodaly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosisCathy Davies, Grazia Rutigliano, Andrea De Micheli, et al.
Pageof 25

Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Frontiers in Psychiatry|May 29, 2019
Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for PsychosisIlaria Bonoldi, Paul Allen, Luis Madeira, et al.
The Journal of Clinical Investigation|January 4, 2021
Atorvastatin is associated with reduced cisplatin-induced hearing lossKatharine A Fernandez, Paul Allen, Maura Campbell, et al.
Psychological Science|June 4, 2021
Correlates of Hallucinatory Experiences in the General Population: An International Multisite Replication StudyPeter Moseley, André Aleman, Paul Allen, et al.
Schizophrenia Bulletin|January 3, 2018
Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second CohortPaul Allen, Matilda Azis, Gemma Modinos, et al.
Biological Psychiatry|February 9, 2025
Transcriptional and Neurochemical Signatures of Cerebral Blood Flow Alterations in Individuals With Schizophrenia or at Clinical High Risk for PsychosisSamuel R Knight, Leyla Abbasova, Yashar Zeighami, et al.
Human Brain Mapping|February 21, 2025
The Psychosis MRI Shared Data Resource (Psy-ShareD)Paul Allen, Mariana Zurita, Rubaida Easmin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 18, 2021
Food-induced anaphylaxis morbidity: Emergency department and hospitalization data support preventive strategiesLuciana Kase Tanno, Evangeline Clark, Myriam Mamodaly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2019
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosisCathy Davies, Yannis Paloyelis, Grazia Rutigliano, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 1, 2019
Neurochemical effects of oxytocin in people at clinical high risk for psychosisCathy Davies, Grazia Rutigliano, Andrea De Micheli, et al.
Pageof 25